Berodual Inhaler

Berodual is a bronchodilator medication used for the prevention and treatment of symptoms in chronic obstructive airway disorders, such as bronchial asthma and chronic bronchitis. It combines two active ingredients: ipratropium bromide, an anticholinergic agent, and fenoterol hydrobromide, a beta-adrenergic agonist. This combination helps to relax the muscles in the airways, facilitating easier breathing. Berodual is available in various forms, including metered-dose inhalers (MDIs) and inhalation solutions, and is manufactured in multiple countries. The brand was originally developed by Boehringer Ingelheim Pharma GmbH & Co. KG in Germany. As of 2026, the ultimate owner of the Berodual brand is Boehringer Ingelheim International GmbH, a global pharmaceutical company headquartered in Germany, specializing in human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. There are no known subsidiaries that own the brand locally.